万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

10.1007/s13238-016-0299-9

An episomal CRISPR/Cas9 system to derive vector-free gene modified mammalian cells

引用
Dear Editor,CRISPR and CRISPR-associated (Cas) proteins play their adaptive immunity role in degrading foreign nucleic acids in both bacteria and archaea.CRISPR/Cas has proved efficient in modifying mammalian genomes (Cong et al.,2013;Mali et al.,2013) and various delivery methods for Cas9:gRNA complex have been established.Among different delivery means,in vitro transcribed Cas9 mRNA/gRNA,purified Cas9 protein,and adeno-associated virus (AAV) driven seem promising toward clinical applications (Kouranova et al.,2016;Lin et al.,2014;Yin et al.,2016).Still,all the fore-mentioned methods for delivering CRISPR/Cas9 have certain shortcomings./n vitro transcription and protein purification are complicated and inconvenient for use,while AAV mediated system suffers from the side effects of immune response and insertional mutagenesis (Donsante et al.,2007;Li et al.,2011).

7

This work was supported by the National Natural Science Foundation of China Grant No.31271598 and The Project for Extramural Scientists of State Key Laboratory of Agrobiotechnology 2015SKLAB6-15.

2016-11-08(万方平台首次上网日期,不代表论文的发表时间)

689-691

相关文献
评论
暂无封面信息
查看本期封面目录

蛋白质与细胞

1674-800X

11-5886/Q

7

2016,7(9)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn